According to KOBAYASHI Pharmaceutical's latest financial reports the company's total debt is A$8.97 Million. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | A$10.27 M | 15.55% |
2022-12-31 | A$8.89 M | 17.78% |
2021-12-31 | A$7.55 M | -12.96% |
2020-12-31 | A$8.67 M | -25.77% |
2019-12-31 | A$11.68 M | -11.88% |
2018-12-31 | A$13.26 M | 50.35% |
2017-12-31 | A$8.82 M | |
2016-03-31 | A$10.04 M | 45.44% |
2015-03-31 | A$6.9 M | -14.84% |
2014-03-31 | A$8.11 M | 85.71% |
2013-03-31 | A$4.36 M | -57.24% |
2012-03-31 | A$10.21 M | -35.58% |
2011-03-31 | A$15.86 M | -62.49% |
2010-03-31 | A$42.28 M | 3.63% |
2009-03-31 | A$40.8 M | 412.88% |
2008-03-31 | A$7.95 M | -77.81% |
2007-03-31 | A$35.86 M | 82.64% |
2006-03-31 | A$19.63 M | -46.4% |
2005-03-31 | A$36.63 M |